Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

33.3%

2 terminated/withdrawn out of 6 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

75%

3 of 4 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 4

1(20.0%)

5Total

N/A(4)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT03532555Not ApplicableTerminated

Enteral Zinc to Improve Growth in Infants at Risk for Bronchopulmonary Dysplasia

Role: collaborator

NCT02926027Phase 4Completed

Effect of Vascepa on Improving Coronary Atherosclerosis in People With High Triglycerides Taking Statin Therapy

Role: collaborator

NCT02573207Terminated

Recovery of Hibernating Myocardium in End Stage Heart Failure

Role: collaborator

NCT02490423Not ApplicableCompleted

Improvement in Medication Adherence Through the Implementation of Personalized Nudges: the ENCOURAGE Trial

Role: collaborator

NCT01917188Not ApplicableCompleted

Promoting Patient-Centered Care Through a Heart Failure Simulation Study

Role: collaborator

NCT01792986Not ApplicableCompleted

The Fasting II Study

Role: collaborator

All 6 trials loaded